Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hideyuki Tsuji is active.

Publication


Featured researches published by Hideyuki Tsuji.


Digestive Diseases and Sciences | 1994

Quantitative detection of hepatitis C virus genome in liver tissue and circulation by competitive reverse transcription-polymerase chain reaction

Hiroshi Nakagawa; Hiroyuki Shimomura; Toshimi Hasui; Hideyuki Tsuji; Takao Tsuji

We quantified hepatitis C virus RNA in 25 Japanese patients with chronic type C liver disease by competitive reverse transcription-polymerase chain reaction. The amount of the viral RNA in the serum (2×105−2×108 copies/ml) correlated with that in the liver tissue (108−1011 copies/g) (N=23,r=0.727,P<0.0001). One gram of the infected liver tissue contained 102−104 (geometric mean, 103,N=23) times as many copies of the viral RNA as did 1 ml of the serum. Liver tissues of chronic aggressive hepatitis contained significantly higher amounts of the viral RNA than those of chronic persistent hepatitis (P<0.05). These observations suggested that this method is useful to evaluate viral amount, and the amount of the circulating hepatitis C virus RNA could be used as a marker of the intrahepatic viral amounts, which might contribute to disease activity.


Digestive Diseases and Sciences | 2001

High prevalence of TT virus in human bile juice samples: importance of secretion through bile into feces.

Mamoru Itoh; Hiroyuki Shimomura; Shinichi Fujioka; Masanobu Miyake; Hideyuki Tsuji; Fusao Ikeda; Takao Tsuji

TT virus (TTV) is much more prevalent than we once imagined. With the use of primers designed from the noncoding regions, a more than 90% rate of TTV infection in the general population by polymerase chain reaction (PCR) has been reported, showing that nonparenteral transmission must play an important role to its epidemiology. We considered that TTV may be secreted through bile juice into feces to establish nonparenteral infection. Paired bile juice and serum samples were obtained from 26 patients who were receiving bile drainage. Feces were also recovered after the drainage tube was removed. TTV DNA was detected from 22 patients in serum (84.6%), and they were all TTV DNA positive in bile juice. Most feces samples recovered from TTV-positive patients were also TTV DNA positive. Secretion of TTV into bile juice appears to be common, and this could play an important role to its transmission and its epidemiology.


Digestive Endoscopy | 1994

Peritoneoscopic Findings of Autoimmune Hepatitis

Masahito Tanimizu; Minoru Ukida; Toshio Ito; Kazuhide Yamamoto; Haruhiko Kobashi; Takeshi Kakio; Nobuyuki Sakai; Nobuhiko Omori; Masaki Omoto; Masayuki Mikami; Sosuke Nakanishi; Toshimi Hasui; Hideyuki Tsuji; Hiroyuki Shimomura; Kosaku Sakaguchi; Takao Tsuji

Abstract: To clarify the morphologic differences between hepatitis C virus (HCVI‐negative autoimmune hepatitis (AIH) and HCV‐positive AIH, peritoneoscopic findings were studied. Among twenty three patients with AIH according to the Japanese criteria (1992), 15 were HCV‐negative and 8 were HCV‐positive. The terms grooved depression, coarse depression, coarse elevation, coarse undulation, and round‐shaped reddish marking (RM) were used in this study to evaluate the peritoneoscopic findings. Grooved depressions, coarse depressions, coarse elevations, coarse undulations and round‐shaped RMs were all common findings (53%, 87%, 73%, 80%, and 80%, respectively) in HCV‐negative AIH patients, but they were less common (13%, 25%, 13%, 13%, and 0%, respectively) in HCV‐positive AIH patients. This study revealed that HCV‐negative AIH patients had different peritoneoscopic findings from HCV‐positive AIH patients. Thus HCV‐negative AIH may be typical AIH, and HCV‐positive AIH may essentially be a subset of type C chronic hepatitis.


Acta Medica Okayama | 2001

Cold activation of serum complement in patients with chronic hepatitis C: Study on activating pathway and involvement of IgG

Yasushi Ishii; Hiroyuki Shimomura; Mamoru Itoh; Masanobu Miyake; Fusao Ikeda; Jiro Miyaike; Shin Ichi Fujioka; Yoshiaki Iwasaki; Hideyuki Tsuji; Takao Tsuji


Acta Medica Okayama | 2002

Mutations in the hepatitis B virus preS2 region and abrogated receptor activity for polymerized human albumin.

Junichi Kondo; Hiroyuki Shimomura; Shin Ichi Fujioka; Yoshiaki Iwasaki; Shinjiro Takagi; Yasuhiro Ohnishi; Hideyuki Tsuji; Kosaku Sakaguchi; Kazuhide Yamamoto; Takao Tsuji


Acta Medica Okayama | 1998

Relationship of serum markers of hepatitis B and C virus replication in coinfected patients.

Hideyuki Tsuji; Hiroyuki Shimomura; Kozo Fujio; Masaki Wato; Junichi Kondo; Toshimi Hasui; Yasushi Ishii; Shinichi Fujioka; Takao Tsuji


Acta Medica Okayama | 1994

Quantitation of Hepatitis C Virus RNA in Liver Tissue as a Predictive Marker of the Response to Interferon Therpay in Chronic Hepatitis C

Toshimi Hasui; Hiroyuki Shimomura; Hideyuki Tsuji; Masaki Wato; Takao Tsuji


Acta Medica Okayama | 1995

Virological and serological characterization of asymptomatic blood donors positive for anti-hepatitis C virus antibody.

Hideyuki Tsuji; Hiroyuki Shimomura; Masaki Wato; Junichi Kondo; Takao Tsuji


Kanzo | 2006

Clinical study of Radiofrequency Ablation under Biliary Duct Cooling via Endoscopic Naso-biliary Drainage

Mamoru Nishimura; Kazuya Kariyama; Akiko Wakuta; Hideyuki Tsuji; Jiro Nanba; Toshihiro Higashi


Acta Medica Okayama | 1993

Disappearance of pulmonary metastases by OK-432 treatment in a case of hepatocellular carcinoma.

Naoki Hino; Toshihiro Higashi; Tooru Ueki; Harushige Nakatsukasa; Souhei Ooguchi; Kouzou Ashida; Kouzou Fujio; Akinobu Takaki; Taiji Yonei; Toshimi Hasui; Hideyuki Tsuji; Takao Tsuji

Collaboration


Dive into the Hideyuki Tsuji's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge